ONC BeOne Medicines Ltd.

NASDAQ
$403.60

BeOne Medicines Ltd. (ONC) is expected to report earnings on February 4, 2027, before the market open. The consensus earnings estimate is $2.87 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.2% since its last earnings release on November 5, 2026.

BeOne Medicines Ltd. Beat Consensus Estimates, Raises Guidance
Thursday, November 5, 2026 · 6:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 6:00 AM ET
Earnings Whisper
-
vs $2.87
Rev est $1.81B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $409.27

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BeOne Medicines Ltd.

BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.